FDA Import Refusal 799-4091132-2/11/2 — MINT HEALTH DRUGS
The FDA refused shipment 799-4091132-2/11/2 from MINT HEALTH DRUGS (Canada) on Nov 8, 2019. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Nov 8, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62LAE29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 75